SPL11 Antibody

What is SPL11 and why are antibodies against it important in research?

SPL11 is a protein that negatively regulates programmed cell death (PCD) and broad-spectrum disease resistance in plants . As a functional U-box E3 ligase, it plays crucial roles in the ubiquitination pathway that targets specific proteins for degradation. Antibodies against SPL11 are vital research tools that enable:

• Detection and quantification of SPL11 protein in different tissues and experimental conditions

• Investigation of SPL11's interactions with proteins like SPIN1 and SPIN6

• Study of SPL11's subcellular localization and temporal expression patterns

• Analysis of post-translational modifications affecting SPL11 function

• Examination of SPL11's role in immune regulation and developmental processes

These antibodies serve as molecular probes that help researchers unravel the complex signaling networks involving SPL11 in plant immunity and development.

What validation methods should be used to confirm SPL11 antibody specificity?

Proper validation is critical to ensure antibody specificity before conducting experiments. For SPL11 antibodies, implement multiple validation approaches:

Table 1: Recommended Validation Methods for SPL11 Antibodies

When validating an SPL11 antibody, genetic controls using spl11 knockout/mutant tissues represent the most definitive approach, as they provide clear negative controls that should show no signal with a specific antibody .

How do SPL11 antibodies compare across different experimental applications?

Different experimental techniques require specific considerations when using SPL11 antibodies:

Table 2: SPL11 Antibody Performance Across Applications

For SPL11, which functions in protein-protein interactions, antibodies that recognize native conformations are particularly valuable for co-immunoprecipitation experiments studying interactions with SPIN1 and SPIN6 .

How should I design experiments to study SPL11's E3 ligase activity using antibodies?

SPL11 functions as an E3 ubiquitin ligase, and studying this activity requires carefully designed experiments:

• In vitro ubiquitination assays:

  • Purify components including E1, E2, MBP:SPL11 (wild-type), MBP:SPL11m (E3 ligase dead mutant), and substrate (e.g., GST:SPIN6)

  • Perform the reaction and analyze by immunoblot with anti-ubiquitin and anti-GST antibodies

  • Look for high molecular weight bands in wild-type SPL11 reactions but not with SPL11m

• In vivo ubiquitination analysis:

  • Immunoprecipitate potential substrates (SPIN1, SPIN6) from plant tissues

  • Perform Western blotting with anti-ubiquitin antibodies

  • Compare ubiquitination patterns between wild-type and spl11 mutant plants

  • Use proteasome inhibitors (MG132) to stabilize ubiquitinated proteins

• Degradation kinetics:

  • Perform cycloheximide chase experiments to monitor protein turnover

  • Use antibodies against SPL11 substrates (SPIN6) to track degradation rates

  • Compare degradation kinetics between wild-type and spl11 mutant backgrounds

  • Quantify protein levels at different time points after cycloheximide treatment

Research has shown that "SPL11 ubiquitinates SPIN6 and degrades it through the 26S proteasome pathway" , making this a valuable model system for studying E3 ligase activity.

What are the optimal conditions for immunoprecipitating SPL11 and its interacting partners?

Effective immunoprecipitation of SPL11 and its binding partners requires optimized conditions:

• Sample preparation:

  • Harvest plant material at appropriate developmental stages (consider diurnal regulation of SPL11 )

  • Use a gentle lysis buffer that preserves protein-protein interactions (e.g., PHEM buffer + 0.5% Triton X-100 )

  • Include protease inhibitors to prevent degradation

  • Consider crosslinking for transient interactions (1% formaldehyde for 10 minutes)

• Immunoprecipitation procedure:

  • Pre-clear lysate with Protein A/G beads to reduce non-specific binding

  • Use 2-5 μg of validated SPL11 antibody per sample

  • Incubate overnight at 4°C with gentle rotation

  • Wash extensively with increasing stringency to remove non-specific interactions

  • Elute under appropriate conditions (native or denaturing depending on downstream applications)

• Controls and validation:

  • Include IgG control from the same species as the SPL11 antibody

  • Use spl11 mutant extracts as negative controls

  • For co-IP, confirm interactions with reverse IP using antibodies against interacting partners

  • Validate interactions with orthogonal methods (yeast two-hybrid as described for SPIN6 )

Research shows that SPL11 interacts with both SPIN1 and SPIN6 in the nucleus, suggesting that nuclear extraction protocols may be particularly important for studying these interactions.

How can I use SPL11 antibodies to investigate its temporal and spatial expression patterns?

Understanding when and where SPL11 is expressed provides valuable insights into its function:

• Temporal expression analysis:

  • SPL11 shows a diurnal expression pattern under short-day conditions, with mRNA levels peaking in the dark and decreasing in midafternoon

  • Collect samples at regular intervals (e.g., every 4 hours) throughout the day/night cycle

  • Extract proteins and perform Western blotting with SPL11 antibodies

  • Quantify protein levels relative to appropriate loading controls

  • Compare protein expression with transcript data to identify post-transcriptional regulation

• Tissue-specific expression:

  • Dissect different plant tissues (roots, stems, leaves, flowers at various developmental stages)

  • Extract proteins using standardized protocols

  • Perform Western blotting with SPL11 antibodies

  • Use tissue-specific markers as controls

  • Compare protein distribution with in situ hybridization data for SPL11 mRNA

• Immunohistochemistry for cellular localization:

  • Fix plant tissues appropriately (4% paraformaldehyde in PHEM buffer )

  • Perform antigen retrieval if necessary

  • Block with 10% boiled donkey serum

  • Incubate with SPL11 antibody at optimized concentration

  • Use fluorescently-labeled secondary antibodies for detection

  • Counter-stain to identify cellular structures

• Subcellular fractionation:

  • Separate plant cell extracts into nuclear, cytoplasmic, and membrane fractions

  • Perform Western blotting with SPL11 antibodies

  • Use compartment-specific markers as controls

  • Quantify relative distribution across fractions

Understanding SPL11's expression patterns is particularly important given its dual roles in immunity and flowering time regulation .

What are the main challenges in detecting SPL11 in plant tissues and how can they be overcome?

Detecting plant proteins like SPL11 presents several challenges:

• Low abundance issues:

  • SPL11 may be expressed at low levels, particularly in certain tissues or conditions

  • Concentrate proteins by immunoprecipitation before Western blotting

  • Use signal amplification methods (enhanced chemiluminescence substrates)

  • Increase sample loading or optimize protein extraction

  • Consider using tyramide signal amplification for immunohistochemistry

• Plant-specific interference:

  • Plant tissues contain compounds that can interfere with antibody binding

  • Add polyvinylpyrrolidone (PVP) to extraction buffers to remove phenolic compounds

  • Include higher concentrations of detergents in wash buffers

  • Perform additional clarification steps (e.g., high-speed centrifugation)

  • Pre-absorb antibodies with plant extracts from spl11 mutants to reduce non-specific binding

• Protein modification and degradation:

  • Include protease inhibitors in all buffers

  • Add phosphatase inhibitors if studying phosphorylation

  • Consider adding deubiquitinating enzyme inhibitors when studying ubiquitination

  • Keep samples cold throughout processing

  • Extract proteins directly into SDS sample buffer for immediate denaturation

• Antibody specificity in plant matrices:

  • Validate antibodies extensively using spl11 mutant controls

  • Perform peptide competition assays to confirm specificity

  • Use recombinant antibody fragments for increased specificity

  • Consider raising species-specific antibodies if working with non-model plants

How should I interpret conflicting results between different SPL11 antibody preparations?

When faced with discrepant results using different SPL11 antibodies:

What quality control measures should be implemented when working with SPL11 antibodies over time?

Maintaining antibody quality and experimental reproducibility requires rigorous quality control:

• Antibody storage and handling:

  • Aliquot antibodies upon receipt to minimize freeze-thaw cycles

  • Store according to manufacturer's recommendations (typically -20°C or -80°C)

  • Include preservatives (e.g., sodium azide) in working dilutions

  • Document lot numbers and preparation dates

• Regular validation:

  • Periodically test antibodies against positive and negative controls

  • Monitor signal-to-noise ratio over time

  • Compare new results to historical data with the same antibody

  • Retain reference samples from successful experiments for comparison

• Standardized protocols:

  • Maintain detailed protocols with exact conditions

  • Use consistent reagent sources and preparations

  • Implement automated systems where possible for consistency

  • Standardize image acquisition settings for comparative analyses

• Performance tracking:

  • Maintain a laboratory database of antibody performance

  • Record batch/lot information and correlation with experimental outcomes

  • Document any troubleshooting steps and optimizations

  • Consider implementing Levey-Jennings charts to track antibody performance over time

How can SPL11 antibodies be used to study the interplay between ubiquitination and other post-translational modifications?

SPL11's function as an E3 ligase makes it an excellent model for studying regulatory post-translational modifications (PTMs):

• Sequential immunoprecipitation approach:

  • First IP: Use antibodies against specific PTMs (phospho-specific, acetylation-specific)

  • Second IP: Re-immunoprecipitate with SPL11 antibodies

  • Western blot analysis to detect modified forms of SPL11

  • Compare modification patterns between different conditions (e.g., pathogen infection)

• Mass spectrometry-based PTM mapping:

  • Immunoprecipitate SPL11 using specific antibodies

  • Perform LC-MS/MS analysis to identify PTMs

  • Quantify changes in modification abundance under different conditions

  • Generate modification-specific antibodies for further validation

• Studying modification-dependent interactions:

  • Compare SPL11 interactomes between wild-type and mutant plants defective in specific PTMs

  • Use phosphatase treatment to determine if interactions are phosphorylation-dependent

  • Analyze how PTMs affect SPL11's E3 ligase activity towards substrates like SPIN6

  • Develop assays to detect modification-dependent conformational changes

• Crosstalk between ubiquitination and other PTMs:

  • Study how phosphorylation of SPL11 affects its E3 ligase activity

  • Investigate whether SPL11-mediated ubiquitination is affected by other PTMs on substrates

  • Create mutation constructs to mimic or prevent specific modifications

  • Use antibodies specific to ubiquitinated forms of SPL11 or its substrates

How can I use SPL11 antibodies to investigate its role in the diurnal regulation of flowering pathways?

SPL11 shows diurnal expression and regulates flowering time , making it an interesting target for chronobiology studies:

• Temporal expression profiling:

  • Collect plant samples at regular intervals (e.g., every 4 hours) throughout 24-48 hour cycles

  • Extract proteins and perform Western blotting with SPL11 antibodies

  • Quantify protein levels relative to appropriate loading controls

  • Compare SPL11 protein oscillations with transcript data

  • Analyze both under short-day and long-day conditions (SPL11 shows diurnal regulation under SD but not LD )

• Protein-protein interaction dynamics:

  • Perform co-IP experiments at different time points to track SPL11-SPIN1 interaction dynamics

  • The research shows "high SPL11 expression tended to correlate with decreased SPIN1 levels"

  • Compare interaction patterns between wild-type and clock mutant backgrounds

  • Analyze how light conditions affect these interactions

• Chromatin association studies:

  • Use ChIP with SPL11 antibodies to study potential DNA association

  • Analyze binding patterns at different times of day

  • Correlate with expression of flowering-related genes

  • Compare between wild-type and spl11 mutant plants

• Protein stability analysis:

  • Track SPL11 and SPIN1 protein levels throughout the day/night cycle

  • Perform cycloheximide chase experiments at different time points

  • Determine if protein stability varies depending on time of day

  • Compare degradation rates between light and dark periods

What approaches can be used to study the role of SPL11 in plant immunity using antibody-based techniques?

SPL11 negatively regulates programmed cell death and disease resistance , offering various immunological research opportunities:

• Immune response dynamics:

  • Challenge plants with pathogens and monitor SPL11 protein levels over time

  • Compare SPL11-SPIN6 interaction before and after pathogen infection

  • Analyze SPL11 subcellular localization during immune responses

  • Study post-translational modifications of SPL11 during infection

• Pathway analysis:

  • Immunoprecipitate SPL11 complexes after pathogen challenge

  • Identify interacting partners using mass spectrometry

  • Research shows SPL11-SPIN6-OsRac1 forms a regulatory module in immunity

  • Compare interactomes between susceptible and resistant plant varieties

• Defense protein regulation:

  • Study how SPL11 affects stability of defense-related proteins

  • Monitor ubiquitination of immune components

  • Analyze expression of "defense-related genes, PR1a, PR5 and PBZ1" in relation to SPL11 levels

  • Investigate how SPL11 affects the transition from pattern-triggered immunity to effector-triggered immunity

• ROS signaling analysis:

  • "Spin6 RNAi and mutant plants show enhanced... ROS generation"

  • Study how SPL11 regulates ROS-producing enzymes

  • Monitor oxidative status of SPL11 during immune responses

  • Analyze how ROS affects SPL11's E3 ligase activity

What quantitative approaches should be used to analyze SPL11 protein levels across different experimental conditions?

Accurate quantification of SPL11 requires rigorous analytical approaches:

• Western blot quantification:

  • Use internal loading controls appropriate for plant samples (e.g., actin, tubulin)

  • Apply densitometric analysis to measure band intensity

  • Ensure signals fall within the linear range of detection

  • Include a standard curve using recombinant SPL11 protein

  • Normalize SPL11 signal to the internal control

  • Use at least three biological and technical replicates for statistical validity

• Statistical analysis considerations:

  • Apply appropriate normality tests before selecting statistical methods

  • Use ANOVA for multi-condition comparisons with appropriate post-hoc tests

  • Account for technical variations between blots using normalization methods

  • Consider using regression analysis for time-course experiments

  • Report effect sizes along with p-values for meaningful interpretation

• Advanced quantification approaches:

  • Consider using automated Western blotting platforms for higher reproducibility

  • Implement multiplexed detection systems to simultaneously quantify SPL11 and interacting partners

  • Use purified standards to establish absolute quantification

  • Apply Bayesian approaches for complex experimental designs with multiple factors

• Visualization and reporting:

  • Present data with appropriate error bars (standard deviation or standard error)

  • Show representative blot images alongside quantification

  • Include all replicates in supplementary material for transparency

  • Report detailed methodology including exposure times and image processing steps

How can I effectively analyze SPL11-protein interactions data from co-immunoprecipitation experiments?

• Quantitative co-IP analysis:

  • Normalize the amount of co-immunoprecipitated protein to the amount of immunoprecipitated SPL11

  • Compare interaction efficiency across different conditions

  • Control for non-specific binding using IgG controls

  • Consider the effects of protein expression levels on interaction detection

• Validation of interactions:

  • Confirm interactions using reverse co-IP (immunoprecipitate the partner and detect SPL11)

  • Verify with orthogonal methods (e.g., yeast two-hybrid assays as used for SPIN6 )

  • Test interaction with truncated or mutated versions to map interaction domains

  • Compare with known interactors like SPIN1 and SPIN6 as positive controls

• Interpreting complex formation:

  • Analyze whether interactions are direct or indirect

  • Test for competition between different interacting partners

  • Investigate whether post-translational modifications affect interaction strength

  • Consider the biological context of detected interactions

• Advanced interaction analysis:

  • Use size exclusion chromatography to study complex formation

  • Apply blue native PAGE to analyze native protein complexes

  • Consider proximity-dependent labeling approaches to capture transient interactions

  • Use structural information to predict and test interaction interfaces

What are the key considerations when interpreting contradictory data about SPL11 function from different antibody-based assays?

Resolving contradictory data requires systematic evaluation:

• Antibody characteristics evaluation:

  • Compare epitope locations - different domains may have distinct functions

  • Assess antibody validation evidence for each assay

  • Consider whether antibodies might recognize different isoforms or modified forms

  • Evaluate potential for epitope masking in protein complexes

• Experimental condition analysis:

  • Compare buffer compositions and their effects on protein conformation

  • Assess whether sample preparation methods preserve relevant protein states

  • Evaluate whether detection methods have appropriate sensitivity and specificity

  • Consider temporal factors in dynamic processes (e.g., diurnal regulation )

• Biological context consideration:

  • SPL11 has dual roles in immunity and development

  • Different tissues or developmental stages may show distinct SPL11 functions

  • Consider whether environmental conditions affect results

  • Evaluate genetic background effects (cultivar differences, mutant backgrounds)

• Integration approaches:

  • Develop models that accommodate seemingly contradictory observations

  • Consider whether contradictions reflect biologically meaningful regulation

  • Use genetic approaches to test hypotheses arising from contradictory data

  • Apply systems biology approaches to place contradictory results in pathway context